TickerFacts.

Company research / USPH

U S Physical Therapy Inc (USPH)

Build a valuation ↗↓ Download CSV

SEC name U S PHYSICAL THERAPY INC /NV · CIK 0000885978 · NYSE · Services-Health Services

  • Sector Services
  • Incorporated NV
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, U S Physical Therapy Inc reported revenue of $780.99M. Revenue grew 16.3% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $812.20M.

Key ratios (year ended 2025-12-31)

19.2%
Gross margin
11.1%
Operating margin
5.1%
Net margin
8.3%
Return on year-end equity
16.3%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-02

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$812.20M$780.99M$671.35M$604.80M$553.14M$495.02M$422.97M$481.97M$453.91M$414.05M$356.55M
Gross Profit$151.70M$149.69M$123.92M$121.51M$112.02M$117.18M$94.45M$112.47M$101.66M$90.62M$82.01M
Operating Income$76.52M$86.68M$62.99M$50.51M$56.80M$70.65M$52.41M$67.42M$60.31M$54.73M$49.53M
Depreciation & Amortization$22.40M$22.39M$18.68M$15.70M$14.74M$11.59M$10.53M$10.10M$9.76M$9.71M$8.78M
EBITDA$98.93M$109.07M$81.67M$66.21M$71.54M$82.24M$62.95M$77.52M$70.07M$64.44M$58.31M
Net Income$32.23M$39.58M$31.42M$28.24M$32.16M$40.83M$35.19M$40.04M$34.87M$22.26M$20.55M
EPS (Diluted)n/a$1.42$1.84$1.28$2.25$2.41$2.48$2.45n/an/an/a
Total Assets$1.25B$1.20B$1.17B$997.24M$858.15M$749.43M$594.36M$630.50M$443.17M$418.98M$351.23M
Total Liabilities$482.22M$433.81M$408.42M$345.00M$373.59M$296.98M$184.39M$181.39M$92.35M$110.34M$162.54M
Long-Term Debtn/an/an/an/an/a$118.42M$21.50M$51.09M$39.84M$60.77M$51.82M
Shareholders' Equity$449.17M$476.89M$490.02M$477.41M$317.05M$297.18M$277.63M$241.70M$216.88M$206.07M$188.69M
Cash & Equivalents$24.89M$35.57M$41.36M$152.82M$31.59M$28.57M$32.92M$23.55M$23.37M$21.93M$20.05M
Operating Cash Flow$83.05M$75.06M$74.94M$81.98M$58.54M$76.41M$100.00M$62.45M$73.00M$56.53M$51.05M
Capital Expenditures$18.98M$14.07M$9.19M$9.29M$8.25M$8.20M$7.64M$10.19M$7.19M$7.09M$8.26M
Free Cash Flow$64.07M$60.99M$65.75M$72.68M$50.29M$68.20M$92.36M$52.26M$65.81M$49.43M$42.79M
Share Repurchases$24.80M$5.57M$0$0n/an/an/an/an/an/an/a
Dividends Paid$27.55M$27.36M$26.54M$24.13M$21.32M$18.77M$4.11M$14.55M$11.66M$10.07M$8.51M
Shares Outstandingn/an/an/an/an/an/an/an/a12.68M12.59Mn/a
Dividends Per Sharen/a$1.80$1.76$1.72$1.64$1.46$0.32$1.14$0.92$0.80$0.68
Weighted Average Diluted Sharesn/a15.18M15.06M14.19M12.98M12.90M12.84M12.76Mn/an/a12.50M
EPS (Basic)n/a$1.42$1.84$1.28$2.25$2.41$2.48$2.45n/an/an/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView